Alzheimer's Disease Research Reports
| Food and Ingredient Trends Addressing Specific Diseases and Other Health Conditions Topics: Obesity, Alzheimer's Disease, Diabetes, Osteoporosis, Functional Foods & Beverages, Ingredients, Soy, Alternative & Complementary Medicine, Wellness/Prevention Programs, Healthcare, Cardiovascular, Oncology/Hematology, Gastrointestinal |
| The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends) Topics: Alzheimer's Disease, Generics Drugs, Research & Development, Drug Discovery, Gerontology/Aging Regions: Global |
| Stakeholder Opinions: Diagnostics in Neurology - Predictive biomarkers expand drug revenues Topics: Genomics, Biomarkers, Alzheimer's Disease, Diagnostics, CNS/Neurology |
| Competitor Analysis: Alzheimer’s Disease Antibodies Topics: Antibody Technologies, Alzheimer's Disease, Drug Discovery |
| Alzheimer's and Parkinson's Disease Topics: Alzheimer's Disease, Parkinson's Disease Regions: Global |
| UpdatesPlus-Nicotinic Receptors Topics: Alzheimer's Disease, CNS/Neurology |
| Emerging Drug Targets in Alzheimer’s Disease Topics: Alzheimer's Disease, Drug Discovery |
| Pipeline Report - Neuronal alpha 7 nicotinic receptors: Candidates for the treatment of Alzheimers disease and Schizophrenia Topics: Alzheimer's Disease, CNS/Neurology |
| Nicotinic Receptor Agonists for Treating Diseases of Cognitive Dysfunction Topics: Alzheimer's Disease, CNS/Neurology |
| Alzheimer's Disease Market Analysis and Forecasts, 2007-2012, 2017 & Topics: Alzheimer's Disease, Prescription Drugs |
| Alzheimer's Disease Clinical Trial Monitoring Brief Topics: Alzheimer's Disease, Research & Development, Prescription Drugs, CNS/Neurology |
| U.S. Alzheimer's Disease Medications Markets Topics: Alzheimer's Disease, Prescription Drugs, CNS/Neurology Regions: United States |
| The Neurotechnology Industry 2007 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System Topics: Obesity, Pain, Alzheimer's Disease, Medical Devices, CNS/Neurology, Behavioral Health |
| Expanding a Brand: Statins and PPAR-Gamma Agonists to Treat Neurological Disease Topics: Alzheimer's Disease, Cardiovascular, CNS/Neurology |
| Potential Breakthroughs in Neurotherapeutics: Alzheimer’s Disease, Parkinson’s Disease, Depression, Bipolar Disorder, and Schizophrenia Topics: Alzheimer's Disease, Parkinson's Disease, Prescription Drugs, Drug Discovery, CNS/Neurology |
| Emerging Targets in Diseases with High Unmet Need: Alzheimer’s Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes, and COPD Topics: Alzheimer's Disease, Asthma, Diabetes, Research & Development, Drug Delivery, Cardiovascular, Respiratory/Pulmonary, Oncology/Hematology |
| Emerging Diagnostic Markers in Alzheimer’s Disease Topics: Alzheimer's Disease |
| Alzheimer's Disease: Selections from "The World Market for Neurotherapeutic Drugs" Topics: Alzheimer's Disease, Prescription Drugs, Gerontology/Aging, CNS/Neurology Regions: Global |
Prev | 1 | 2 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
